Aristo Bio-Tech and Lifescience Limited (NSE:ARISTO)
131.00
-0.10 (-0.08%)
At close: Jul 11, 2025
NSE:ARISTO Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2019 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2019 - 2020 |
Cash & Equivalents | 11.16 | 54.13 | 38.03 | 26 | 1.12 | Upgrade
|
Cash & Short-Term Investments | 11.16 | 54.13 | 38.03 | 26 | 1.12 | Upgrade
|
Cash Growth | -79.39% | 42.32% | 46.25% | 2215.58% | -78.61% | Upgrade
|
Accounts Receivable | 561.84 | 574.73 | 445.73 | 332 | 327.66 | Upgrade
|
Other Receivables | - | - | 19.37 | - | - | Upgrade
|
Receivables | 666.58 | 574.73 | 465.11 | 332 | 327.66 | Upgrade
|
Inventory | 473.66 | 401.87 | 307.77 | 243.62 | 319.45 | Upgrade
|
Prepaid Expenses | - | - | - | - | 0.51 | Upgrade
|
Other Current Assets | 6.22 | 19.53 | 15.53 | 23.79 | 42.29 | Upgrade
|
Total Current Assets | 1,158 | 1,050 | 826.44 | 625.42 | 691.03 | Upgrade
|
Property, Plant & Equipment | 239.52 | 216.79 | 167.15 | 144.58 | 123.12 | Upgrade
|
Other Intangible Assets | 0.01 | 0.01 | 0.01 | 0.02 | 0.03 | Upgrade
|
Long-Term Deferred Tax Assets | - | - | 0.08 | - | - | Upgrade
|
Other Long-Term Assets | 9.1 | 5.81 | 4.6 | -0 | - | Upgrade
|
Total Assets | 1,406 | 1,273 | 998.29 | 770.02 | 814.17 | Upgrade
|
Accounts Payable | 784.06 | 688.64 | 446.04 | 352.13 | 383.51 | Upgrade
|
Accrued Expenses | 19.22 | 10.15 | 11.6 | 5.19 | 5.36 | Upgrade
|
Short-Term Debt | 142.14 | 78.51 | 99.44 | 126.68 | 93.04 | Upgrade
|
Current Portion of Long-Term Debt | - | 30.28 | 23.8 | 17.26 | 8.84 | Upgrade
|
Current Income Taxes Payable | - | 13.87 | 12.62 | 4.74 | 3.45 | Upgrade
|
Other Current Liabilities | 10.34 | 14.23 | 1.35 | 3.41 | 65.53 | Upgrade
|
Total Current Liabilities | 955.76 | 835.68 | 594.86 | 509.39 | 559.73 | Upgrade
|
Long-Term Debt | 76.4 | 99.96 | 101.66 | 110.91 | 120.6 | Upgrade
|
Long-Term Deferred Tax Liabilities | 0.77 | 1.14 | - | 0.86 | 0.04 | Upgrade
|
Other Long-Term Liabilities | - | 0 | 0.22 | 0.2 | 0 | Upgrade
|
Total Liabilities | 1,033 | 936.78 | 696.74 | 621.36 | 680.37 | Upgrade
|
Common Stock | 68.08 | 68.08 | 68.08 | 49.95 | 49.95 | Upgrade
|
Retained Earnings | - | - | - | 98.71 | 83.86 | Upgrade
|
Comprehensive Income & Other | 305.24 | 268.01 | 233.48 | - | - | Upgrade
|
Shareholders' Equity | 373.31 | 336.09 | 301.55 | 148.66 | 133.81 | Upgrade
|
Total Liabilities & Equity | 1,406 | 1,273 | 998.29 | 770.02 | 814.17 | Upgrade
|
Total Debt | 218.54 | 208.76 | 224.9 | 254.84 | 222.48 | Upgrade
|
Net Cash (Debt) | -207.39 | -154.63 | -186.87 | -228.84 | -221.35 | Upgrade
|
Net Cash Per Share | -30.47 | -22.71 | -35.25 | -45.81 | -44.32 | Upgrade
|
Filing Date Shares Outstanding | 6.81 | 6.81 | 6.81 | 5 | 5 | Upgrade
|
Total Common Shares Outstanding | 6.81 | 6.81 | 6.81 | 5 | 5 | Upgrade
|
Working Capital | 201.85 | 214.57 | 231.59 | 116.02 | 131.3 | Upgrade
|
Book Value Per Share | 54.85 | 49.37 | 44.30 | 29.76 | 26.79 | Upgrade
|
Tangible Book Value | 373.31 | 336.08 | 301.54 | 148.64 | 133.78 | Upgrade
|
Tangible Book Value Per Share | 54.85 | 49.37 | 44.29 | 29.76 | 26.78 | Upgrade
|
Land | - | 56.24 | 56.24 | 56.24 | 33.83 | Upgrade
|
Buildings | - | 110.72 | 62.78 | 61.01 | 73.94 | Upgrade
|
Machinery | - | 134.94 | 108.3 | 82.13 | 60.98 | Upgrade
|
Construction In Progress | - | - | 10.97 | 0.98 | - | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.